August 13, 2025
Press Release
Vividion Therapeutics Appoints Sam Whiting, M.D., Ph.D., as Chief Medical Officer
June 4, 2025
Press Release
Vividion Therapeutics and Bayer Further Strengthen Oncology Development Pipeline with Clinical-Stage WRN Inhibitor
April 3, 2025
Press Release
Vividion Therapeutics Doses First Patient in Phase I Study of RAS-PI3Kα Inhibitor for Treatment of Advanced Solid Tumors
January 22, 2025
Press Release
Vividion Therapeutics Announces Promotion of Jean Bemis to Chief Operating Officer
January 8, 2025
Press Release
Vividion Therapeutics Acquires Tavros Therapeutics to Expand Functional Genomics Capabilities and Boost Drug Discovery Platform
